TPP1 and Ataxia: The clinical signs of CLN2 disease include speech delay, gross motor delay, seizures and ataxia typically evident from 2 to 4 years of age, followed by rapid neurocognitive decline, deterioration in motor and visual abilities, and early death in the first decade of life7–10.